Bio-Techne Corp at Cowen HealthCare Conference Transcript
All right. Good morning. I'm [Chris] from the life science tools and diagnostics research team. With me today is Bio-Techne. From Bio-Techne, we have Jim, who is CFO. He's going to go right through a presentation, and we have a breakout session next door.
So with that, let me turn it over to Jim.
Great. Thank you. Great to be here. Thanks for joining me early this morning. It's our first time our company has been at the Cowen conference. So it's a pleasure to be here.
Of course, our safe harbor statement and forward-looking statements, you can go to our website and read that in detail.
To start with just an overview generally of our company. Bio-Techne is actually a 40-year-old life science tools company, historically known for its reagents portfolio, primarily proteins, antibodies and immunoassays, immunoassay kits. But over the last 6 or 7 years, we've been transforming the company from what was kind of a rather sleepy, privately run public
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |